This publication was developed and produced by the National Center for Chronic Disease Prevention and Health Promotion of the Centers for Disease Control and Prevention in consultation with the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology.
The data included in this report were provided by the Society for Assisted Reproductive Technology under Contract No. 200–98–106 for the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Publication support was provided by Palladian Partners, Inc., under Contract No. GS—23F–0270L for the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. The Centers for Disease Control and Prevention (CDC), the Society for Assisted Reproductive Technology, and the American Society for Reproductive Medicine thank RESOLVE: The National Infertility Association and The American Fertility Association (AFA) for their commitment to assisted reproductive technology surveillance. Their assistance in making this report informative and helpful to people considering an ART procedure is greatly appreciated. Appendix D has current contact information for these national consumer organizations. The Division of Reproductive Health in CDC’s National Center for Chronic Disease Prevention and Health Promotion also thanks the following individuals for their many contributions and support of this effort. Heather Breeze Clayton, M.P.H., Association of Schools of
Public Health
Implementation of the Fertility Clinic Success Rate and Certification Act of 1992 Assisted Reproductive Technology: Embryo Laboratory Date last reviewed: 03/23/2006Content source: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion |
|
|
||||||||||||
|